Bioventus Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Bioventus
BVS Stock  USD 12.92  0.19  1.49%   
Bioventus financial statements provide useful quarterly and yearly information to potential Bioventus investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bioventus financial statements helps investors assess Bioventus' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bioventus' valuation are summarized below:
Gross Profit
302.7 M
Profit Margin
(0.08)
Market Capitalization
842.2 M
Enterprise Value Revenue
2.1999
Revenue
536.9 M
There are over one hundred nineteen available fundamental signals for Bioventus, which can be analyzed over time and compared to other ratios. All traders should validate Bioventus' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 1.2 B in 2024, whereas Market Cap is likely to drop slightly above 313.6 M in 2024.

Bioventus Total Revenue

386.8 Million

Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.7 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
  
Check out the analysis of Bioventus Correlation against competitors.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Bioventus Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding63.5 M62.6 M57.4 M
Slightly volatile
Total Assets788.8 M810.9 M608.8 M
Slightly volatile
Short and Long Term Debt Total292.3 M409.5 M232.8 M
Slightly volatile
Other Current Liabilities121.6 M115.8 M40.1 M
Slightly volatile
Total Current Liabilities148.1 M175.5 M104.3 M
Slightly volatile
Total Stockholder Equity240.5 M173.6 M199.4 M
Slightly volatile
Property Plant And Equipment Net27.7 M50 M18.7 M
Slightly volatile
Current Deferred Revenue5.2 M5.5 M39.9 M
Pretty Stable
Net Debt247.3 M372.5 M198 M
Slightly volatile
Accounts Payable15.2 M23 M10.9 M
Slightly volatile
Cash45 M37 M34.8 M
Slightly volatile
Non Current Assets Total576.9 M542.9 M446.8 M
Slightly volatile
Cash And Short Term Investments45 M37 M34.8 M
Slightly volatile
Net Receivables100.7 M123 M77.8 M
Slightly volatile
Good Will7.1 M7.5 M48.9 M
Pretty Stable
Common Stock Total Equity64.1 K67.5 K140.4 M
Pretty Stable
Liabilities And Stockholders Equity788.8 M810.9 M608.8 M
Slightly volatile
Non Current Liabilities Total379.4 M414.3 M293.7 M
Slightly volatile
Inventory52.8 M91.3 M39.9 M
Slightly volatile
Other Current Assets12.7 M16.7 M9.3 M
Slightly volatile
Total Liabilities527.5 M589.8 M398.1 M
Slightly volatile
Property Plant And Equipment Gross95 M90.5 M25.9 M
Slightly volatile
Total Current Assets212 M268 M162.1 M
Slightly volatile
Short Term Debt21.8 M31.9 M14.8 M
Slightly volatile
Intangible Assets475.1 M482.4 M366.8 M
Slightly volatile
Common Stock75 K79 K140.4 M
Pretty Stable
Other Liabilities207.2 M197.3 M82.8 M
Slightly volatile
Other Assets31.3 M58.1 M24.3 M
Slightly volatile
Property Plant Equipment17.4 M26.4 M13.6 M
Slightly volatile
Long Term Debt301.1 M367 M230.7 M
Slightly volatile
Net Invested Capital574.1 M568.4 M428.4 M
Slightly volatile
Long Term Investments2.9 M3 M5.7 M
Slightly volatile
Short and Long Term Debt20 M27.8 M11.4 M
Slightly volatile
Capital Stock75 K79 K209.1 M
Slightly volatile
Non Current Liabilities Other44.4 M46.1 M22 M
Slightly volatile
Short Term Investments15.5 M17.4 M19 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity59.9 M67.4 M73.4 M
Slightly volatile
Capital Surpluse372.2 M418.7 M456 M
Slightly volatile
Deferred Long Term Liabilities106.8 M120.2 M130.8 M
Slightly volatile

Bioventus Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization40.7 M57.4 M33.7 M
Slightly volatile
Interest Expense42.7 M40.7 M18.1 M
Slightly volatile
Total Revenue386.8 M512.3 M325.8 M
Slightly volatile
Gross Profit266.4 M319.4 M226.6 M
Slightly volatile
Other Operating Expenses378.3 M496.3 M318.6 M
Slightly volatile
Research Development15.1 M13.4 M12.5 M
Slightly volatile
EBITDA51 M73.4 M42 M
Slightly volatile
Cost Of Revenue120.4 M193 M99.2 M
Slightly volatile
Total Operating Expenses257.9 M303.3 M219.3 M
Slightly volatile
Selling General Administrative264.4 M286 M216 M
Slightly volatile
Reconciled Depreciation48.2 M73.2 M36.4 M
Slightly volatile
Selling And Marketing Expenses4 M3.9 M2.9 M
Slightly volatile
Non Recurring6.5 M7.3 M8 M
Slightly volatile

Bioventus Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow53.6 M30.2 M43.5 M
Slightly volatile
Depreciation40.8 M57.4 M33.7 M
Slightly volatile
Capital Expenditures8.5 M7.4 M9 M
Pretty Stable
End Period Cash Flow51.7 M37 M45.4 M
Slightly volatile
Dividends Paid5.5 M3 M4.7 M
Slightly volatile
Change To Netincome18.1 M10.7 M24.4 M
Slightly volatile
Change To Liabilities13.8 M20.9 M11.1 M
Slightly volatile
Cash And Cash Equivalents Changes10.1 M11.3 M12.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.610.64443.2164
Slightly volatile
Dividend Yield4.0E-44.0E-40.0042
Very volatile
PTB Ratio1.811.90195.2755
Slightly volatile
Days Sales Outstanding71.4787.659382.3441
Slightly volatile
Book Value Per Share3.243.52963.5749
Slightly volatile
Stock Based Compensation To Revenue0.0050.00530.0214
Slightly volatile
Capex To Depreciation0.120.12830.2825
Pretty Stable
PB Ratio1.811.90195.2755
Slightly volatile
EV To Sales1.31.37153.6924
Slightly volatile
Inventory Turnover2.842.11312.7203
Pretty Stable
Days Of Inventory On Hand117173137
Pretty Stable
Payables Turnover12.068.377211.7152
Slightly volatile
Sales General And Administrative To Revenue0.460.55830.5696
Very volatile
Research And Ddevelopement To Revenue0.04460.02620.0417
Slightly volatile
Capex To Revenue0.01370.01440.0292
Pretty Stable
Cash Per Share0.570.590.5929
Slightly volatile
Days Payables Outstanding31.4743.570634.8467
Slightly volatile
Intangibles To Total Assets0.730.6040.6884
Slightly volatile
Net Debt To EBITDA3.985.07684.5879
Pretty Stable
Current Ratio1.771.52711.7665
Pretty Stable
Receivables Turnover4.574.16384.4807
Slightly volatile
Graham Number13.0912.4696.3769
Slightly volatile
Shareholders Equity Per Share2.992.77093.3927
Pretty Stable
Debt To Equity2.412.29791.2891
Slightly volatile
Capex Per Share0.210.11750.1628
Pretty Stable
Revenue Per Share4.678.17825.4272
Slightly volatile
Interest Debt Per Share3.847.01674.2062
Slightly volatile
Debt To Assets0.430.49190.4008
Very volatile
Enterprise Value Over EBITDA9.19.576226.0651
Slightly volatile
Operating Cycle189260219
Slightly volatile
Price Book Value Ratio1.811.90195.2755
Slightly volatile
Days Of Payables Outstanding31.4743.570634.8467
Slightly volatile
Company Equity Multiplier2.654.67142.994
Slightly volatile
Long Term Debt To Capitalization0.420.67890.5148
Slightly volatile
Total Debt To Capitalization0.440.69680.5307
Slightly volatile
Debt Equity Ratio2.412.29791.2891
Slightly volatile
Quick Ratio1.351.00671.3451
Pretty Stable
Cash Ratio0.420.21060.3961
Pretty Stable
Cash Conversion Cycle157217184
Slightly volatile
Days Of Inventory Outstanding117173137
Pretty Stable
Days Of Sales Outstanding71.4787.659382.3441
Slightly volatile
Price To Book Ratio1.811.90195.2755
Slightly volatile
Fixed Asset Turnover9.7410.255527.8746
Pretty Stable
Enterprise Value Multiple9.19.576226.0651
Slightly volatile
Debt Ratio0.430.49190.4008
Very volatile
Price Sales Ratio0.610.64443.2164
Slightly volatile
Asset Turnover0.630.63180.5907
Very volatile
Gross Profit Margin0.760.62330.6977
Very volatile
Price Fair Value1.811.90195.2755
Slightly volatile

Bioventus Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap313.6 M330.2 M900.9 M
Slightly volatile
Enterprise Value1.2 B702.7 M1.1 B
Slightly volatile

Bioventus Fundamental Market Drivers

Forward Price Earnings17.9211
Cash And Short Term Investments37 M

Bioventus Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M5.2 M
Total Revenue512.3 M386.8 M
Cost Of Revenue193 M120.4 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.56  0.46 
Research And Ddevelopement To Revenue 0.03  0.04 
Capex To Revenue 0.01  0.01 
Revenue Per Share 8.18  4.67 
Ebit Per Revenue 0.03  0.03 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY